【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-003825 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-003820 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-003823 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2022-02-08,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,15普通股, $3.27
$Neuronetics(STIM)$ 内部交易: 2022-02-07,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,4716普通股, $3.26
$Neuronetics(STIM)$ 内部交易: 2022-02-09,CFO,Furlong Stephen ,卖出,166普通股, $3.14
$Neuronetics(STIM)$ 内部交易: 2022-02-08,CFO,Furlong Stephen ,卖出,5184普通股, $3.12
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-003327 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-003328 Size: 6 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-22-003561 Act: 34 Size: 161 KB 网页链接